In the United States, cannabis remains a Schedule I drug. This means it's not only deemed illegal and considered to have no medical benefits, but also that the government considers consumers are prone to abuse.
Notwithstanding, a majority of Americans support patient access.
As we head towards the 2020 Presidential election, cannabis reform has certainly become a hot-button issue, with majority of the Democratic candidates favoring legalization at the federal level.
In this context, we’re witnessing the debut of "Weediatrics: A Covert Medical Mission," a soon-to-be-released film that follows a group of all-American families on their clandestine quest to acquire and use medical cannabis (illegally), to help their extremely sick children, as our country continues to fight over its legalization and debates its medicinal benefits. These brave parents are now showing their face, risking everything, in the hopes of creating national legislative change.
“We didn’t set out to make a pro-marijuana movie. In a time where the country at large feels that there is so much progress being made in the legalization of marijuana, this film reveals the painful truth,” the film's director John Ehrhard told Benzinga.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Missed the first wave of cannabis investments? Don’t make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
Just this year, the PotProfits portfolio has seen smoking-hot gains like:
- 47.10% with $GTBIF
- 40.23% with $TCNNF
- 21.50% with $VFF